Q32 Bio (QTTB) Net Margin (2018 - 2023)
Q32 Bio (QTTB) recorded quarterly Net Margin of 1957.52% in Q4 2023, down 159.36% quarter-over-quarter from 754.76% in Q3 2023, and up 235295.0% on a YoY basis from N/an in Q4 2022.
Q32 Bio (QTTB) Net Margin (2018 - 2023) Analysis & Trends
Q32 Bio's Net Margin history runs 6 years deep, the most recent figure standing at 1957.52% for Q4 2023.
- In Q4 2023, Net Margin rose 235295.0% year-over-year to 1957.52%; the TTM figure through Sep 2024 stood at 508.95% (up 120390.0% YoY), while the FY2025 annual figure was 0.06%, changed N/A from the prior year.
- Net Margin was 1957.52% for Q4 2023 at Q32 Bio, down from 754.76% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 11553.99% in Q1 2022 to a low of 8834.07% in Q1 2019.
- Historically, Net Margin has averaged 2876.41% across 5 years, with a median of 3714.28% in 2022.
- The sharpest annual moves came in 2022 and 2023: Net Margin surged 1155765 bps in 2022, then plunged 1178602 bps in 2023.
- A 5-year view of Net Margin shows it stood at 4292.54% in 2019, then grew by 29 bps to 3039.9% in 2020, then sank by 38 bps to 4187.41% in 2021, then dropped by 3 bps to 4310.47% in 2022, then soared by 55 bps to 1957.52% in 2023.
- The last three Net Margin figures came in at 1957.52% (Q4 2023), 754.76% (Q3 2023), and 181.19% (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.82% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 34.53% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Q32 Bio | 167.59 Mn | 116.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -1,957.52% |
| Sep 30, 2023 | -754.76% |
| Jun 30, 2023 | -181.19% |
| Mar 31, 2023 | -232.03% |
| Dec 31, 2022 | -4,310.47% |
| Sep 30, 2022 | -3,945.01% |
| Jun 30, 2022 | -3,483.54% |
| Mar 31, 2022 | 11,553.99% |
| Dec 31, 2021 | -4,187.41% |
| Sep 30, 2021 | -1,825.16% |
| Jun 30, 2021 | -1,394.60% |
| Mar 31, 2021 | -3.66% |
| Dec 31, 2020 | -3,039.90% |
| Sep 30, 2020 | -4,979.19% |
| Jun 30, 2020 | -6,232.80% |
| Mar 31, 2020 | -6,008.67% |
| Dec 31, 2019 | -4,292.54% |
| Sep 30, 2019 | -6,718.14% |
| Jun 30, 2019 | -6,701.53% |
| Mar 31, 2019 | -8,834.07% |